June 14, 2022
Emeryville, CA – SLINGSHOT BIOSCIENCES, INC. the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Almog Diagnostic, a private company established in 1987 [...]
June 14, 2022
Merck today announced that it has entered a collaboration with Agilent Technologies to advance Process Analytical Technologies (PAT). Collaboration will help enable real-time release and Bioprocessing 4.0 Merck to offer integrated capabilities for downstream process monitoring and control Online Process Analytical Technologies a critical tool towards implementing continuous manufacturing to realize Bioprocessing 4.0 DARMSTADT, GERMANY [...]
June 14, 2022
NORWOOD, Mass. -- Advanced Instruments, a global provider of scientific and analytical instruments and services for bioprocessing, is excited to announce the implementation of the complete Solentim Ecosystem at Wheeler Bio in Oklahoma City, OK. Wheeler is a biologics development company that connects customers with an open-source, transfer-ready biologics production platform through their unique service offering called Portable [...]
June 14, 2022
New NeuraLight 3D Ultra Module Expands Neuroscience Research Capabilities MADISON, Wis. -- Bruker Corporation (Nasdaq: BRKR) today announced the release of the NeuraLight 3D Ultra™module to support advanced neuroscience and optogenetics research applications on Bruker’s Ultima multiphoton microscopes. NeuraLight 3D Ultra provides revolutionary 3D holographic photostimulation, specifically optimized for functional and large-scale studies of neural networks and brain computation. [...]
seqWell appoints Dr Amy Liao to Board of Directors
June 14, 2022
BEVERLY, Mass. – seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, today announced the appointment of Dr Amy Liao to its Board. Amy joins the current Board of Directors, led by Chairman Paul McEwan. The appointment supports the commercial development of the Company’s existing and future products, following its recent $7M Series [...]
Development underway for a new generation, multi-omic biological age clock
June 14, 2022
LEXINGTON, Ky. -- TruDiagnostic announces a new collaboration with Brigham's Women's Hospital and Seer Inc. to produce a next-generation age predictor developed using a combination of proteomic, genomic, metabolomic, epigenetic and complete clinical covariates. The resulting clock will represent a new generation of biological age prediction. The project represents a joint effort between TruDiagnostic Inc, a [...]
June 14, 2022
Tapestri Center of Excellence program expands globally to offer Tapestri’s single-cell multi-omics capabilities across Europe SOUTH SAN FRANCISCO, Calif. and BARCELONA, Spain — Mission Bio, Inc., the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced a new Center of Excellence, located at the Josep Carreras Leukaemia Research Institute and led by Manel Esteller, MD, PhD. [...]
Syapse, Pierian Announce Genomics Collaboration to Power Precision Oncology
June 14, 2022
SAN FRANCISCO -- Syapse®, a leading real-world evidence company announced with Pierian®, a global leader in advanced clinical genomics technology, a new joint collaboration that will benefit patients of the AdventHealth Cancer Institute in Central Florida. The collaboration combines Syapse’s real-world evidence solutions designed to improve outcomes for patients with cancer, Pierian’s leading-edge clinical genomics workflow, and [...]
Cambridge Epigenetix Names Peter Fromen as Chief Executive Officer
June 14, 2022
Genomics Veteran to Lead Company Which Has a Commercial-Ready Novel Technology Platform that Can Realize the Largely Untapped Contribution of Epigenetics to Human Health CAMBRIDGE, United Kingdom -- Cambridge Epigenetix (CEGX), a life sciences tools and technology company which is revolutionizing genome sequencing, today announced the appointment of Peter J. Fromen as Chief Executive Officer [...]
SLINGSHOT BIOSCIENCES, INC. PARTNERS WITH OZYME TO DISTRIBUTE SYNTHETIC CELLS THROUGHOUT FRANCE
June 14, 2022
Emeryville, CA (June 14, 2022) – SLINGSHOT BIOSCIENCES, INC. the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Ozyme, a French company dedicated [...]

